Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-Cell acute lymphoblastic Leukemia/lymphoblastic lymphoma

被引:46
作者
Li, SY [1 ]
Juco, J [1 ]
Mann, RP [1 ]
T Holden, J [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
thymoma; precursor T-cell acute lymphoblastic leukemia; T-cell lymphoblastic lymphoma; flow cytometric immunophenotyping;
D O I
10.1309/K2FY1TED8GEGFLNG
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We compared the antigen expression profile of thymocytes in lymphocyte-rich thymoma with that of precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-cell ALL/LBL) cells using 4-color flow cytometry. In all 15 thymoma cases, the thymocytes demonstrated 3 distinct subpopulations. The least mature cells (double-negative) expressed low-density CD2 and CD5, high-density CD7, CD10, CD34, and heterogeneous CD4 and CD8. They had the lowest density CD45 expression and were surface CD3-. The immature cells (double-positive) expressed CD2, CD5, CD7, CD4, CD8, heterogeneous surface CD3, and intermediate-density CD45. They were CD10- and CD34-. The mature cells (single-positive) expressed CD2, surface CD3, CD5, CD7, and CD4 or CD8. The heterogeneous expression of surface CD3, CD4, and CD8 also created a characteristic smearing pattern for these antigens. In all 15 T-cell ALL/LBL cases, the lymphoblasts formed a tight cluster without discrete subpopulations or smearing pattern. Of 5 double-negative cases, 4 demonstrated loss of CD2, CD10, or CD34 expression. Of 7 double-positive cases, 5 showed complete loss of surface CD3, CD2, and/or CD5; 4 were CD10+; and 2 were CD34+. Of 3 single-positive cases, 2 showed loss of CD2 and/or aberrant expression of CD34. Analysis of antigen expression pattern, the presence or absence of T cell-associated antigen deletion, and the expression of CD10 and CD34 by 4-color flow cytometry can help differentiate thymoma from T-cell ALL/LBL.
引用
收藏
页码:268 / 274
页数:7
相关论文
共 22 条
[1]   Thymoma - Cytopathologic features and differential diagnosis on fine needle aspiration [J].
Ali, SZ ;
Erozan, YS .
ACTA CYTOLOGICA, 1998, 42 (04) :845-854
[2]   THYMOMA - A MULTIVARIATE-ANALYSIS OF FACTORS PREDICTING SURVIVAL [J].
BLUMBERG, D ;
PORT, JL ;
WEKSLER, B ;
DELGADO, R ;
ROSAI, J ;
BAINS, MS ;
GINSBERG, RJ ;
MARTINI, N ;
MCCORMACK, PM ;
RUSCH, V ;
BURT, ME .
ANNALS OF THORACIC SURGERY, 1995, 60 (04) :908-914
[3]   Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis - A retrospective study of 90 tumors [J].
Chalabreysse, L ;
Roy, P ;
Cordier, JF ;
Loire, R ;
Gamondes, JP ;
Thivolet-Bejui, F .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1605-1611
[4]  
Friedman HD, 1996, DIAGN CYTOPATHOL, V14, P165, DOI 10.1002/(SICI)1097-0339(199603)14:2<165::AID-DC12>3.0.CO
[5]  
2-K
[6]   Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors [J].
Fujii, Y ;
Okumura, M ;
Yamamoto, S .
JOURNAL OF SURGICAL RESEARCH, 1999, 82 (02) :312-318
[7]   A study on CD45 isoform expression during T-Cell development and selection events in the human thymus [J].
Fukuhara, K ;
Okumura, M ;
Shiono, H ;
Inoue, M ;
Kadota, Y ;
Miyoshi, S ;
Matsuda, H .
HUMAN IMMUNOLOGY, 2002, 63 (05) :394-404
[8]   DIAGNOSIS OF METASTATIC THYMOMA USING FLOW-CYTOMETRY [J].
GATZIMOS, KR ;
MORIARTY, AT ;
PINGLETON, JM ;
MCCLOSKEY, DW .
PATHOBIOLOGY, 1992, 60 (03) :168-172
[9]  
Hoerl HD, 2000, DIAGN CYTOPATHOL, V23, P417, DOI 10.1002/1097-0339(200012)23:6<417::AID-DC12>3.0.CO
[10]  
2-4